Shalin Shah of Marius Pharmaceuticals - Past, present, and future of testosterone therapy

[madman]

At the Clinical Application of Longevity Medicine 2026 conference, cardiologist and longevity physician Dr. Abid sits down with Shalin of Marius Pharmaceuticals — makers of Kyzatrex, the FDA-approved oral testosterone — for a candid conversation about the past, present, and future of testosterone therapy.

Shalin shares his unlikely path from investor to pharmaceutical founder, driven by his own experience with low testosterone and a decade-long mission to bring a safer, more convenient oral option to market. They discuss testosterone's critical role in vascular, metabolic, muscular, and neurological health — for both men and women.

The conversation spotlights The Testosterone Project — Marius' advocacy initiative pushing for universal testosterone testing, descheduling of testosterone, and an FDA-approved female indication. Upcoming studies pairing Kyzatrex with GLP-1s to address sarcopenia are also teased.

 

[madman]

Thread 'KYZATREX (oral testosterone undecanoate) Updates'

Oct 16, 2022

KYZATREX™ (testosterone undecanoate capsules)

The Power of Hormonal Balance | Restore your T- levels with Two KYZATREX capsules a day. | Discover KYZATREX Rediscover CONFIDENCE | A solution sans needles, gels, or creams

www.kyzatrex.com

KYZATREX (testosterone undecanoate) is an oral testosterone replacement therapy specifically designed for adult males with conditions associated with a deficiency or absence of endogenous testosterone, such as primary hypogonadism and hypogonadotropic hypogonadism 1112. Here is detailed information regarding its dosage, usage, side effects, price, and efficacy:

Dosage​

KYZATREX is available in capsule form in three dosage strengths: 100 mg, 150 mg, and 200 mg. The recommended starting dose is 200 mg...

• madman
• kyzatrex; oral t; hypogonadism
• Replies: 78
• Forum: Testosterone Basics & Questions

•